Form 4 for GILD Gilead Sciences
Accepted 2026-05-04 16:36:45 ET · period of report 2026-04-30 · accession 0001183680-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-04 16:36 | 2026-04-30 | GILD | BARTON JACQUELINE K | Dir | A - Grant | $0.00 | +1,146 | 27.2K | +4% | $0 |
| D | 2026-05-04 16:36 | 2026-04-30 | GILD | BARTON JACQUELINE K | Dir | A - Grant | $0.00 | +4,884 | 4,884 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-30 | A | A | 1,146 | $0.00 | 27,202 | D | — | — | (F1) Represents 1,146 restricted stock units ("RSUs") granted under the Gilead Sciences, Inc. 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. The RSUs vested immediately upon the grant date of April 30, 2026. |
| 2 | Derivative | Non-qualified Stock Option (Right to Buy) | 2026-04-30 | A | A | 4,884 | $0.00 | 4,884 | D | $130.84 · — to 2036-04-30 | 4,884 Common Stock | (F2) 100% of the shares subject to the stock option vested immediately upon the grant date of April 30, 2026. |